Anbio Biotechnology (NNNN) Current Assets (2023 - 2025)

Historic Current Assets for Anbio Biotechnology (NNNN) over the last 3 years, with Q2 2025 value amounting to $27680.6 billion.

  • Anbio Biotechnology's Current Assets changed N/A to $27680.6 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $27680.6 billion, marking a year-over-year change of. This contributed to the annual value of $18534.3 billion for FY2024, which is 11768103170.4% up from last year.
  • Latest data reveals that Anbio Biotechnology reported Current Assets of $27680.6 billion as of Q2 2025.
  • Anbio Biotechnology's Current Assets' 5-year high stood at $27680.6 billion during Q2 2025, with a 5-year trough of $15.7 million in Q4 2023.
  • Its 3-year average for Current Assets is $15405.0 billion, with a median of $18534.3 billion in 2024.
  • Over the last 5 years, Anbio Biotechnology's Current Assets had its largest YoY gain of 11768103170.4% in 2024, and its largest YoY loss of 11768103170.4% in 2024.
  • Anbio Biotechnology's Current Assets (Quarter) stood at $15.7 million in 2023, then skyrocketed by 117681031.7% to $18534.3 billion in 2024, then soared by 49.35% to $27680.6 billion in 2025.
  • Its Current Assets stands at $27680.6 billion for Q2 2025, versus $18534.3 billion for Q4 2024 and $15.7 million for Q4 2023.